Vol. 11 (02) pp. 1079-1084 DOI: 10.21474/IJAR01/16346

MEDICAL MANAGEMENT OF OCULAR SARCOIDOSIS

, and
  • Junior Resident, Department Of Ophthalmology, Government Medical College and Hospital, Aurangabad.
  • Head of Department, Department of Ophthalmology, Government Medical College and Hospital, Aurangabad.
  • Professor, Department of Ophthalmology, Government Medical College and Hospital, Aurangabad.
10 Downloads 74 Views
Crossref

Download Full Paper (PDF)

Abstract

Sarcoidosis is one of the leading causes of inflammatory eye disease. Ocular sarcoidosis can involve any part of the eye and its adnexal tissues, and may cause uveitis, episcleritis/scleritis, eyelid abnormalities, conjunctival granuloma, optic neuropathy, lacrimal gland enlargement and orbital inflammation. Glaucoma and cataract can be complications from inflammation itself or adverse effects from therapy. Ophthalmic manifestations can be isolated, or associated with other organ involvement. Patients with ocular sarcoidosis can present with a wide range of clinical presentations and severity. Multi-disciplinary approaches are required to achieve the best treatment outcomes for both ocular and systemic manifestations. 

Keywords

How to Cite This Article

Ruchika Y. Jumle, Kashinath G. Choudhary and Shubha C. Ghonsikar (2023); MEDICAL MANAGEMENT OF OCULAR SARCOIDOSIS, International Journal of Advanced Research (IJAR), 11 (02), 1079-1084, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/16346

Corresponding Author

Ruchika Y. Jumle
Dr
India

Article Analytics

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.